GLP-1 Drugs Surge: Reducing Obesity and Bariatric Surgery Rates
Ozempic’s GLP-1 Revolution: A Public Health Shift or Overhyped Trend? In 2026, Ozempic (semaglutide) has emerged as a landmark treatment for obesity, with new data showing sustained weight loss and ... Read More